{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005306,73,MONDO:0005306,133,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005306","source":"MONDO:0005306|ankylosing spondylitis","targets":["NCT00133315|TNFalfa Blocking Treatment of Spondylarthropathies|COMPLETED|PHASE4|INTERVENTIONAL","NCT00247962|Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00410046|Extension Study Evaluating Etanercept in Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00420238|Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00432432|Combination Methotrexate and Infliximab|COMPLETED|PHASE4|INTERVENTIONAL","NCT00444340|An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00458185|Study Evaluating Etanercept in Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00507403|Infliximab and Methotrexate in Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00647517|Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00715091|Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00873730|Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain|COMPLETED|PHASE4|INTERVENTIONAL","NCT00910273|Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients|TERMINATED|PHASE4|INTERVENTIONAL","NCT00936143|Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00953979|Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01148901|Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01212653|Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01422564|Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem|TERMINATED|PHASE4|INTERVENTIONAL","NCT01517620|Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01668004|The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01895764|Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01934933|Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02132234|Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02313727|Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02489760|Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02492217|Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT02528201|A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02638896|Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02758782|NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02763046|Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03350815|Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03411798|Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03473665|Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis|TERMINATED|PHASE4|INTERVENTIONAL","NCT03639740|Treat-to-target With Secukinumab in Axial Spondyloarthritis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03800797|Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03932006|A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04077957|Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04885751|Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04934059|Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05080218|COVID-19 VaccinE Response in Rheumatology Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT05164198|REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05303285|A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis|RECRUITING|PHASE4|INTERVENTIONAL","NCT05527444|The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT06707194|Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis|RECRUITING|PHASE4|INTERVENTIONAL","NCT06833112|Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT00085644|Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00195819|Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00207701|A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00235105|D2E7-Early AS|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00244166|Prednisolone in Active Ankylosing Spondylitis (AS)|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00356356|16.0040 Ankylosing Spondylitis Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT00367211|Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00418548|Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00421915|Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00421980|An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00432653|Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00434044|Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00439283|Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00478660|An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00576706|PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity|COMPLETED|PHASE3|INTERVENTIONAL","NCT00667355|A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00762463|Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00844805|Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00889694|Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01091675|Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs|COMPLETED|PHASE3|INTERVENTIONAL","NCT01114880|Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT01248793|Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT01358175|16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT01586650|Effects of Aerobic Training in Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT01694264|Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα|TERMINATED|PHASE3|INTERVENTIONAL","NCT02186873|A Study of Golimumab in Participants With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT02469753|Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes|COMPLETED|PHASE3|INTERVENTIONAL","NCT02505542|Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo|COMPLETED|PHASE3|INTERVENTIONAL","NCT02685904|A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis|TERMINATED|PHASE3|INTERVENTIONAL","NCT02750592|Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT02762812|Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT02809781|A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT03259074|Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)|COMPLETED|PHASE3|INTERVENTIONAL","NCT03447704|International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT03502616|Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)|COMPLETED|PHASE3|INTERVENTIONAL","NCT03928743|A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT04135508|A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira|COMPLETED|PHASE3|INTERVENTIONAL","NCT04156620|Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA|COMPLETED|PHASE3|INTERVENTIONAL","NCT04345458|Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT04436640|A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT04480359|Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT04481139|A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT04483687|Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT04483700|Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT04840485|Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT05376189|Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT05861102|Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05861128|Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)|UNKNOWN|PHASE3|INTERVENTIONAL","NCT06000956|A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo|RECRUITING|PHASE3|INTERVENTIONAL","NCT06378697|A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis|RECRUITING|PHASE3|INTERVENTIONAL","NCT07237568|A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis|RECRUITING|PHASE3|INTERVENTIONAL","NCT07261644|A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)|RECRUITING|PHASE3|INTERVENTIONAL","NCT07277179|Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00004288|Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis|COMPLETED|PHASE2|INTERVENTIONAL","NCT00126724|Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT00243750|Methotrexate in Ankylosing Spondylitis (MTX in AS)|UNKNOWN|PHASE2|INTERVENTIONAL"]}]}